Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 12, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	24,121	24,169	29,075	52,058	32,706	29,701
Market Cap Growth	14.97%	-16.87%	-44.15%	59.17%	10.12%	187.42%
Enterprise Value	24,476	25,024	30,396	54,143	34,595	30,425
Last Close Price	14.93	14.87	17.73	31.59	20.25	18.30
PE Ratio	-	-123.94	26.47	47.15	39.88	47.58
PS Ratio	6.15	6.15	7.83	14.12	11.22	12.03
PB Ratio	3.85	4.17	4.71	9.64	8.73	9.89
P/FCF Ratio	28.27	20.14	231.92	214.34	-38.02	-31.04
P/OCF Ratio	15.64	14.93	48.83	76.15	-57.80	-35.30
EV/Sales Ratio	6.31	6.37	8.19	14.69	11.87	12.32
EV/EBITDA Ratio	-70.21	-138.35	26.18	40.86	34.17	42.41
EV/EBIT Ratio	-47.76	-75.30	29.76	43.96	37.28	45.25
EV/FCF Ratio	28.69	20.85	242.46	222.93	-40.22	-31.80
Debt / Equity Ratio	0.37	0.45	0.48	0.38	0.87	0.46
Debt / EBITDA Ratio	-	-	2.56	1.55	3.22	1.92
Debt / FCF Ratio	2.71	2.16	23.70	8.45	-3.79	-1.44
Asset Turnover	0.38	0.40	0.41	0.46	0.46	0.58
Inventory Turnover	0.76	0.67	0.34	0.34	0.32	0.46
Quick Ratio	1.43	0.86	0.96	0.88	0.80	0.44
Current Ratio	3.13	2.35	3.07	3.06	2.41	2.11
Return on Equity (ROE)	-6.46%	-3.17%	18.78%	23.26%	23.61%	22.35%
Return on Assets (ROA)	-3.05%	-2.13%	7.01%	9.66%	9.06%	9.91%
Return on Capital (ROIC)	-3.36%	-2.37%	7.70%	10.65%	10.19%	11.79%
Earnings Yield	-1.77%	-0.78%	3.75%	2.03%	2.46%	2.04%
FCF Yield	3.54%	4.97%	0.43%	0.47%	-2.63%	-3.22%
Dividend Yield	0.64%	0.67%	0.65%	0.37%	0.44%	0.75%
Payout Ratio	0.00%	-	20.78%	18.10%	32.40%	16.64%
Buyback Yield / Dilution	1.71%	3.03%	-2.98%	0.43%	-0.94%	0.52%
Total Shareholder Return	2.35%	3.71%	-2.33%	0.79%	-0.50%	1.27%

Source: S&P Capital IQ. Standard template. Financial Sources.